Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01787604
Other study ID # STAR
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2011
Est. completion date November 20, 2015

Study information

Verified date March 2019
Source Meshalkin Research Institute of Pathology of Circulation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Authors hypothesize that aortic root reimplantation procedure is superior over standard aortic valve reimplantation procedure in the incidence of aortic valve replacement.


Description:

A single blind prospective randomized superiority study is conducted. Our hypothesis is that there is difference in the incidence of aortic valve replacement between the standard aortic valve reimplantation procedure and aortic root reimplantation procedure more than 21.1%. If there is truly difference between groups (Aortic Root Reimplantation Procedure and Aortic Valve Reimplantation Procedure), then total 64 patients for both groups are required to be 80% sure that the upper limit of a one-sided 95% confidence interval would reveal a difference in favour of the Aortic Root Reimplantation Procedure of 21.1%. The blinding process is applied to a patient, who is informed about received valve-sparing operation, but don't know the type of the last. The study was approved by Institutional Review Board. Depending on a type of the procedure, the patients are divided into two groups: Aortic Root Reimplantation Procedure group includes 32 patients and Aortic Valve Reimplantation Procedure group consists of 32 patients. Randomization is conducted intraoperatively by using accidental sampling after examining the aortic valve and making a decision on the possibility of a valve-sparing operation.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date November 20, 2015
Est. primary completion date November 20, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Aortic insufficiency 2+

- Ascending aorta or aortic root of greater than 4.5 cm (> 4.0 cm in Marfan syndrome)

- Good conditions of aortic cusps

Exclusion Criteria:

- Aortic annulus more than 32 mm

- Aortic cusps destruction

- Critical aortic cusps elongation

- Aortic root dissection

Study Design


Intervention

Procedure:
Aortic Root Reimplantation Procedure
Modified Florida Sleeve.
Aortic Valve Reimplantation Procedure
David I

Locations

Country Name City State
Russian Federation Meshalkin State Research Institute of Circulation Pathology Novosibirsk

Sponsors (1)

Lead Sponsor Collaborator
Meshalkin Research Institute of Pathology of Circulation

Country where clinical trial is conducted

Russian Federation, 

References & Publications (2)

?????????? ?. ?., ???? ?. ?., ?????? ?. ?., ?????? ?. ?., ??????? ?. ?. ?????????? ????????????? ????? ????? ? ?????? ? ????????? ? ?????????? ??????????? ?????? ????? ? ???????????????? ??????????? ???????. ????????? ?????????????? ? ??????????????. 2015

Alexander Chernyavskiy, Sergey Alsov, Dmitry Khvan, Dmitry Sirota. Extravalvular exoprosthetic repair of aortic root: first experience. Kardiochirurgia i Torakochirurgia Polska 2012; 9 (4): 409-414 DOI: 10.5114/kitp.2012.32675

Outcome

Type Measure Description Time frame Safety issue
Primary Freedom From Aortic Insufficiency More Than 2+ (Percentage, Kaplan-Meier) Estimated percentage of participants free from aortic insufficiency (AI) more than 2+ measured by echocardiography for a 4 years after treatment.. up to 4 yeras
Secondary Survival (Percentage, Kaplan-Meier) Estimated percentage of alive participants for 4 years after treatment. up to 4 yeras
See also
  Status Clinical Trial Phase
Recruiting NCT04149600 - Identification of Genetic Causes of Calcific Aortic Valve Disease
Enrolling by invitation NCT04035356 - HAART Annuloplasty Device Valve Repair Registry
Unknown status NCT01201070 - Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery Phase 4
Active, not recruiting NCT04281771 - Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI N/A
Completed NCT03644784 - Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.
Recruiting NCT02288871 - Pilot Trial: Comparison of Flow Patterns N/A
Completed NCT01651780 - Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH Phase 3
Completed NCT01171625 - Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX N/A
Terminated NCT00598598 - Echocardiographic Assessment of Cardiovascular Changes in Long Term Space Flight N/A
Recruiting NCT05295628 - Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR N/A
Recruiting NCT06034028 - J-Valve TF Early Feasibility Study N/A
Recruiting NCT06295068 - Evaluation of ARi With OpSens SavvyWire
Completed NCT05742789 - Effect of Anesthetics on Troponin I and С-reactive Protein Phase 1
Recruiting NCT05172973 - ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves N/A
Completed NCT00727181 - An Observational, Prospective Evaluation of the Trifecta™ Valve N/A
Active, not recruiting NCT04415047 - The JenaValve ALIGN-AR Pivotal Trial N/A
Not yet recruiting NCT02623907 - China Valve Registry Study-1 N/A
Completed NCT00478803 - Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root. CAVIAAR Phase 3
Completed NCT00475267 - Aortic Valve Replacement With Trifecta(TM) N/A
Completed NCT00001314 - Investigation of Heart Function in Patients With Heart Valve Defects N/A